Clinical Trial Update: A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated whether repeat dosing of esomeprazole alters the pharmacokinetics of SB-751689 in healthy participants; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Esomeprazole (Esomeprazole)
• SB-751689 (SB-751689)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED